( AMEX:PTN )

News from palatin technologies, inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Feb 26, 2016, 07:30 ET Palatin Technologies Presents Bremelanotide Alcohol Interaction Study at International Society for the Study of Women's Sexual Health Annual Meeting

Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...


Feb 16, 2016, 07:30 ET Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2016 Results; Teleconference and Webcast to be held on February 16, 2016

Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...


Feb 10, 2016, 07:30 ET Palatin Technologies, Inc. to Report Second Quarter Fiscal Year 2016 Results

Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its second quarter, fiscal year 2016 operating results on Tuesday, February 16, 2016...


Feb 08, 2016, 07:30 ET Palatin Technologies Strengthens Intellectual Property Surrounding Use of Bremelanotide for Female Sexual Dysfunction

Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...


Feb 04, 2016, 07:30 ET Palatin Technologies To Present At The BIO CEO & Investor Conference

Palatin Technologies, Inc. (NYSE MKT: PTN) announced that it will be presenting at the 18th Annual BIO CEO & Investor Conference. Hosted by the...


Dec 10, 2015, 07:30 ET Palatin Technologies Achieves Target Patient Enrollment in Pivotal Phase 3 Studies for Bremelanotide for Female Sexual Dysfunction

Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...


Nov 12, 2015, 07:30 ET Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2016 Results; Teleconference and Webcast to be held on November 12, 2015

 Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...


Nov 10, 2015, 09:42 ET Palatin Technologies, Inc. to Report First Quarter Fiscal Year 2016 Results; Teleconference and Webcast to be held on November 12, 2015

Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its first quarter, fiscal year 2016 operating results on Thursday, November 12, 2015...


Sep 28, 2015, 07:30 ET Preclinical Data on PL-3994 for Heart Failure and Resistant Hypertension Presented at 2015 Heart Failure Society of America Annual Meeting

 Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...


Sep 21, 2015, 07:30 ET Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2015 Results

 Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...


Sep 21, 2015, 07:00 ET Palatin Technologies and Richter Terminate License Agreement for Bremelanotide for Female Sexual Dysfunction

 Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...


Sep 16, 2015, 16:01 ET Palatin Technologies, Inc. To Report Fourth Quarter Fiscal Year End 2015 Results

Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its fourth quarter, fiscal year end 2015 operating results on Monday, September 21, 2015...


Aug 18, 2015, 20:13 ET Palatin Technologies Supports FDA's Approval of the First-Ever Treatment for Female Sexual Dysfunction

 Palatin Technologies, Inc. (NYSE MKT: PTN) is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...


Jul 06, 2015, 07:30 ET Palatin Technologies Completes $30 Million Financing

 Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...


Jun 04, 2015, 17:35 ET Palatin Supports FDA Advisory Committee's Recommendation to Approve the First-Ever Treatment for Hypoactive Sexual Desire Disorder

 Palatin Technologies, Inc. (NYSE Amex: PTN) - Today's FDA Advisory Committee's recommendation for the approval of flibanserin is an important...


May 13, 2015, 07:30 ET Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on May 13, 2015

 Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...


May 08, 2015, 07:30 ET Palatin Technologies, Inc. To Report Third Quarter Fiscal Year 2015 Results

Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its third quarter, fiscal year 2015 operating results on Wednesday, May 13, 2015 before...


Mar 06, 2015, 16:01 ET Palatin Technologies To Present At The 27th Annual ROTH Conference

 Palatin Technologies, Inc. (NYSE MKT: PTN) announced today that it will be presenting at the 27th Annual ROTH Conference on Wednesday, March...


Feb 20, 2015, 07:30 ET Palatin Launches reconnectstudy.com in Support of Bremelanotide Phase 3 Program for Female Sexual Dysfunction

 Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...


Feb 13, 2015, 07:30 ET Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on February 13, 2015

 Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...


Feb 09, 2015, 16:39 ET Palatin Technologies, Inc. To Report Second Quarter Fiscal Year 2015 Results Teleconference and Webcast to be held on February 13, 2015

 Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its second quarter, fiscal year 2015 operating results on Friday, February...


Feb 06, 2015, 16:01 ET Palatin Technologies To Present At The BIO CEO & Investor Conference

 Palatin Technologies, Inc. (NYSE MKT: PTN) announced that it will be presenting at the 17th Annual BIO CEO & Investor Conference. Hosted...


Dec 29, 2014, 07:30 ET Palatin Announces Start of Bremelanotide Phase 3 Program For Female Sexual Dysfunction

 Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...


Dec 24, 2014, 07:30 ET Palatin Completes $20 Million Equity and $10 Million Debt Financings

Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...


Nov 18, 2014, 07:30 ET Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on November 18, 2014

 Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...